BRUSSELS — Activists from a cancer survivor group threw what appeared to be ashes over the EU’s health chief in protest at Europe’s new rules relaxing pesticide use.
Commissioner for Health Olivér Várhelyi was about to deliver a speech at a cancer summit on the EU’s work to curb the disease when two protesters got on stage and threw a grey, dusty substance on him.
“I am a cancer patient; I’m protesting against omnibus law,” said one of the activists from French group Cancer Colère. “These are the ashes of the people you will kill with the pesticides,” said another. One of the protestors was Fleur Breteau, a French writer and activist. The other could not be identified.
The Commission presented theomnibus as a way to clear the backlog of pesticides waiting for approval, to make life easier for farmers. But it is strongly opposed by many civil society groups.
More than 2,000 scientists have signed a letter calling for the proposal to be put on hold until an independent impact assessment is carried out. Consumer group Foodwatch took the issue to the European Ombudsman, accusing the Commission of maladministration, and NGOs have organized multiple protests.
More than 300 NGOs — including environmental organizations, beekeepers’ associations and pesticide victims’ groups, plus doctors and scientists — from 25 European countries will gather outside the European Parliament in Strasbourg at 2 p.m. on Nov. 24 to express discontent with the omnibus.
Video taken at The Hotel in Brussels on Nov. 19, 2026. | Emma Pirnay/POLITICO
Várhelyi brushed off the dust, visibly displeased, and continued with his speech as planned.
“What sort of people are you?” he remarked. “As I was saying, good morning, I’m a bit surprised that in the name of victims of cancer, they dare to splash the ashes of those who have died.”
“This is beyond anything we could have imagined. We are sorry,” Elisabetta Zanon, head of the European Cancer Organisation, told the audience.
Europe’s population is aging, with an increased burden of chronic diseases: more than half of adults in the European Union are now overweight and one in six is obese.1 In parallel, we are exposed to new threats from biosecurity, the malicious use of artificial intelligence, climate-related health threats and drug-resistant superbugs.
We are not passive bystanders. European teachers, biologists, nurses and manufacturers have all played a role in developing innovations that protect our populations and help them thrive. Now is not the time to step back. We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs. Backing research in health as a pillar of our future in a global race is the right choice. It enables Europe to lead and support sustainable growth, as a pillar of the new architecture of global health.
We believe health research and innovation are economic drivers of Europe’s future, not discretionary costs.
The evidence is all around us. A vaccine developed against tuberculosis has been a frontline bladder cancer treatment for over 40 years,2 technology first developed for a malaria vaccine now helps protect millions against shingles,3 and mRNA research, developed over decades, enabled Europe’s fastest-ever vaccine response to Covid-19.4 Scientific progress rarely remains confined to the place or problem where it begins.
Public budgets are under pressure, but these achievements show what investment in global health research can deliver. Pressure can be a catalyst, focusing minds, sharpening priorities and turning constraints into innovative breakthroughs. Too often, the debate is framed in terms of what Europe gives. Too rarely is it framed in terms of what Europe and its people receive in return. With commitment, we can find pragmatic ways to maximize our investments as a union.
Building on its strengths in life sciences, Europe can advance its health sovereignty and seize the emerging opportunities in scientific discovery, next-generation vaccines and biomanufacturing. Basic and applied research become new technologies, intellectual property, skilled jobs and revenues that protect European health, growth and wealth. Together, these returns are Europe’s Health Dividend.
Europe’s health, security and prosperity depend on its ability to contribute to, and benefit from, global networks of research and innovation. Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.
Retreating from global research would not reduce vulnerability; it would increase it. Investing and engaging beyond our borders is a strategic imperative for Europe.
At a time when public investment must deliver its value, we can find ways to maximize the impact of European money by working and funding a shared agenda together, not as disjointed nations. Health research remains one of the clearest examples of an investment that strengthens Europe’s future while delivering benefits today.
Kluemper A, Morris K, Mellon MJ. From plague to the promise: The journey of Bacille Calmette–Guérin. Bladder. 2024;11(4):e21200022. https://doi.org/10.14440/bladder.2024.0035
The advertisement is linked to investment in global health research and development and its contribution to Europe’s health, security, resilience and economic competitiveness.
Cancer claims 10 million lives each year, the global shortage of health workers runs into the millions, and in some parts of the world, a single mosquito bite can be fatal.
These challenges may seem very different. Yet they share a common element in how many health systems operate: risk is often recognised only after it has become illness, outbreak or crisis. By then, a disease may have advanced, transmission of disease may be under way, or an already stretched workforce may be managing consequences that earlier action could have reduced.
The opportunity is to move that point of intervention earlier. This is what anticipatory health means in practice: using signals that already exist, at the bedside, in communities, and in routine health data, to help people and health systems act sooner. It is not prediction for its own sake. The value lies in connecting early and everyday signals to a timely, practical response.
Finding practical routes to earlier action
That principle sits at the heart of the Future Health Impact Challenge: Building Anticipatory Health Systems through Population Sensing, launched by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. The Challenge received 393 submissions from 68 countries. ThinkMD, VectorCam and Huna emerged as its three award-winning solutions: ThinkMD received the grand prize, with VectorCam and Huna recognised as distinguished finalists.
Future Health Impact Challenge: Trailer
The Challenge was designed to identify practical solutions with evidence of impact and potential to scale. Each of the three selected teams demonstrated their approach to using technology to turn an early signal into decisions that support anticipatory actions a health system can take.
Frontline care as a population signal
ThinkMD starts with the interaction between a frontline health worker and a patient. Its offline mobile platform guides structured assessments aligned with clinical protocols, supporting providers where doctors, connectivity, and diagnostic tools may be scarce. Almost 10,000 frontline health workers across 885 facilities are now using it.
Each consultation also creates structured data. Across facilities, that information can reveal changes in symptoms and service demand. In Zambia, analysis of around one million encounters identified symptom patterns several months before a confirmed cholera outbreak. In Kenya, deployment data showed improvements in identifying danger signs in infants and prescribing antibiotics correctly for childhood pneumonia.
It is not prediction for its own sake.
“The utilisation of AI in healthcare is an absolute game changer. Not only can we increase access for patients, but we can also increase access to information to make correct and appropriate diagnoses and give the right treatment to the right patient at the right time. Future Health has been a really critical platform to be able to accelerate our mission of moving from reactionary to anticipatory care,” said Dr Jackie Rabec of ThinkMD.
The award has given ThinkMD support and visibility as it works to expand into new health systems and strengthen how frontline data becomes timely intelligence for decision-makers. That is one measure of the Challenge’s impact: helping proven solutions move towards sustained, wider adoption.
Earlier signals from the environment and routine data
VectorCam begins with the environment around a community. Using a low-cost smartphone imaging device and offline AI, community health workers can photograph and identify mosquitoes in the field. Each observation generates time- and location-based data that can help authorities see changing vector risk as the first signal of disease patterns, before a spread in local communities and populations.
The value lies in connecting early and everyday signals to a timely, practical response.
Field evaluations show data completeness rising from approximately 60% to more than 90%. With support from the Future Health Impact Challenge, VectorCam aims to strengthen its early-warning capability, integrate additional data sources and expand into national surveillance programmes.
Huna looks for earlier cancer-risk signals in information that health systems already generate. Its platform analyses routine complete blood count data to identify people with an elevated risk and prioritises them for screening. It does not diagnose cancer from a blood test; it helps direct limited screening capacity, and supports patients and healthcare professionals through the next steps.
In Brazil, Huna’s deployments have screened more than 500,000 people and detected hundreds of cancer cases. Its experience also highlights a critical ‘last mile’: identifying risk is not enough if a person does not complete the diagnostic pathway. Recognition and funding from the Challenge could help support further validation across new populations and facilitate new international partnerships.
Innovation is only the starting point
Together, these solutions show that useful signals can come from a variety of sources – including clinical encounters, environmental surveillance, and routine diagnostics. They also show that anticipatory approaches can be built where connectivity, specialist capacity, or access to screening is limited, and that innovation developed in those settings can share insights that can be localised and adopted globally.
But a successful technology or pilot is not the same as system-wide impact. Scaling requires local validation, integrated into existing workflows, responsible data governance, sustainable financing, workforce training, and evidence that earlier insight changes decisions and outcomes.
A successful technology or pilot is not the same as system-wide impact.
“The solutions emerging from this Challenge reflect both the urgency and the opportunity facing health systems globally. By bringing innovators together with policymakers, funders and implementers through platforms such as Future Health, we can help accelerate solutions that are locally grounded and capable of delivering impact at scale,” said Hala Hanna, Executive Director of MIT Solve.
From recognition to system-level impact
The Future Health Impact Challenge is part of Future Health’s wider role as a year-round platform for action. Together with our partners and colleagues across diverse sectors and geographies, Future Health identifies promising solutions, supports their development, builds international connections and brings together the policy, clinical, research and investment expertise needed to move from proof to concept to measurable impact.
The Future Health impact documentary film is now available to watch, and shares personal commentary from the founders of the three companies, local stories of the solutions in action, and commentary from the Challenge owners and collaborator.
Watch the full Future Health Impact Challenge Film here.
You remember everything, Cancer. The birthday someone forgot three years ago. The offhand comment a coworker made in a meeting that no one else even caught. The exact tone your sibling used during that fight over the holidays. You forgive people, and you mean it, but you also keep a mental file on every slight, just in case you need it later. That memory makes you a wonderful friend and a fiercely loyal partner. It also means you’re hauling around a lot of old baggage that isn’t yours to carry. This month, the Moon gives you two big chances to set some of it down for good. You’ve earned a lighter load.
The first one comes on the 9th, with a New Moon in Scorpio. New Moons are fresh starts, the moment in the lunar cycle when the sky goes dark and you get to plant something new. This one falls in a fellow water sign, which means it speaks your language. Scorpio energy is intense and private, and it doesn’t flinch at emotional stuff most people would rather avoid. For you, it’s a chance to open that mental file and look at what’s inside. Which grudges are still protecting you? Which ones are just taking up space at this point? You don’t have to decide everything that night. Just take inventory. Grab a notebook and be truthful with yourself.
Pick one old hurt to work on and make it your intention for the lunar cycle. Maybe it’s a friendship that cooled after a misunderstanding, or a family member you’ve been holding at arm’s length since a fight you both barely remember the details of. Maybe it’s something you’re still angry at yourself about. Write it down, say it to someone you trust, or simply sit with it in the dark for a few minutes. Scorpio is the sign of transformation, and a New Moon here is fertile ground for letting something old finally die so that something better can grow in its place.
The days after the New Moon are about small steps. As the Moon starts to wax, your energy builds along with it, and you’ll feel more ready to act on whatever came up for you on the 9th. That might look like sending a text you’ve drafted ten times. It could also be a decision to retire an old argument you keep dragging into new disagreements with your partner. Progress can be small and still count. You’re a cardinal sign, which means you’re better at initiating than people give you credit for. Use that instinct to get the ball rolling, even if you take it slow.
Around the middle of the month, expect some resistance. The first-quarter phase of any lunar cycle can throw obstacles in your path, and with grudges, the obstacle is usually your own pride. You might find yourself rehearsing the speech about how badly someone hurt you, or scrolling back through old messages for proof that you were right. Give yourself a moment to feel it, then put the phone down. Call a friend who’ll hear you out without fanning the flames. A win on paper won’t make you feel half as good as finally letting it go. You can hold people accountable for what they did without letting it set up permanent residence in your head.
The second big chance comes on the 24th, when the Full Moon rises in Gemini. Full Moons bring things to a head and illuminate whatever you’ve been working on since the New Moon. Gemini is an air sign that loves conversation, so this is a natural moment to talk things through. If there’s a conversation you’ve been avoiding, the Full Moon gives you the courage to have it. Keep it simple. Say what hurt, say what you need going forward, and give the other person a chance to respond. Gemini energy thrives on curiosity, so try asking a question or two before you decide how the story ends.
Not every conversation will end with a hug, and that’s okay. Some people will meet you halfway, and some won’t be able to. The Full Moon shows you which relationships can grow past an old wound and which ones have run their course. Either answer tells you something you needed to know, so trust what you see. If someone does meet you there, let that sink in, and let the old file on them close for good. If they don’t, you can grieve the relationship you hoped for and move forward anyway. You’ve been carrying their part of the story, too. Hand it back to them. That takes guts, and you’ve got them.
The Moon moves through your own sign from the 26th to the 28th, right as the holidays kick off, and you’ll feel more like yourself than you have all month. Home is your favorite place, and these few days are perfect for cooking, nesting, and spending time with the people who make you feel safe. Make the dishes you grew up with, or start a brand-new tradition of your own. If you’re gathering with family, you might notice how much lighter you feel around someone you used to brace yourself around. That’s the work from earlier in the month paying off. Let yourself enjoy it. You’ll laugh more easily when you’re not keeping score.
You love hard, Cancer, and you remember hard too. Both come from the same big heart, and neither one is a flaw. This month asks you to keep the memories that teach you something and release the ones that only hurt. You can still be careful with who you let close. You can still have boundaries and enforce them. You just don’t have to relive every injury to protect yourself from the next one. By the end of the month, that mental file should be a little thinner, and you’ll have more room for the people and moments that have earned a permanent place in your heart.
Thus concludes your monthly highlights. For more specific celestial analyses, make sure to read your daily and weekly horoscope as well. Good luck, Cancer! See you next month.
Pope Leo XIV underwent surgery earlier this week, which led to a diagnosis of lung cancer on Tuesday. At a recent health checkup, doctors had discovered a small nodule in the 71-year-old pontiff’s lung, known as adenocarcinoma. It is a common form of non-small-cell lung cancer and was removed by cutting it out. The Vatican also released a statement saying the lower lobe of the pope’s right lung was removed, but that he experienced no complications from the procedure and returned to his room. It is the first significant medical procedure of the pope’s tenure.
“You can heal from a lung tumor,” Dr. Lorenzo Spaggiari, a thoracic surgical oncologist at the European Institute of Oncology in Milan, told the New York Times. Spaggiari, who is not part of the pope’s medical team, also said one of his patients ran the New York Marathon after having a lung removed. “The important thing is to catch it [at] an initial stage,” he said.
Leo was elected as head of the Roman Catholic Church in May 2025, the first American to hold the role. In that short time, members of the Trump administration have repeatedly clashed with the pope, with President Donald Trump once accusing him of being “soft on crime.” Leo has been outspoken about Trump’s war against Iran and immigration policy, urging Catholics to “welcome the stranger.”